1.0Allphase Pharma Consulting, LLChttps://allphasepharma.com/dirHaraldhttps://allphasepharma.com/dir/author/haraldeva/rich600338<blockquote class="wp-embedded-content" data-secret="iP8yR8klgB"><a href="https://allphasepharma.com/dir/2016/04/21/2446/quo-vadis-cdi-drugs/">Quo Vadis, CDI Drugs?</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://allphasepharma.com/dir/2016/04/21/2446/quo-vadis-cdi-drugs/embed/#?secret=iP8yR8klgB" width="600" height="338" title="“Quo Vadis, CDI Drugs?” — Allphase Pharma Consulting, LLC" data-secret="iP8yR8klgB" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://allphasepharma.com/dir/wp-includes/js/wp-embed.min.js </script> https://i0.wp.com/allphasepharma.com/dir/wp-content/uploads/2016/04/CDI-slider-copy.jpg?fit=640%2C180&ssl=1640180There are only 3 CDI drugs in wider clinical use: vancomycin, metronidazole, and fidaxomicin. They are from totally different classes and have almost nothing in common except for proven efficacy in C. difficile infection (CDI). Like vancomycin, the entire group of glycopeptide drugs seems to have good activity against C. Continue reading →